Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Versor Investments LP

Versor Investments LP decreased its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 75.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 401 shares of the biotechnology company’s stock after selling 1,227 shares during the quarter. Versor Investments LP’s holdings in Axon Enterprise were worth $238,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Groupama Asset Managment purchased a new stake in shares of Axon Enterprise during the third quarter worth about $200,000. Massachusetts Financial Services Co. MA acquired a new stake in Axon Enterprise in the 3rd quarter worth approximately $120,553,000. Proficio Capital Partners LLC purchased a new stake in Axon Enterprise during the 4th quarter worth approximately $78,414,000. Westfield Capital Management Co. LP increased its stake in Axon Enterprise by 12.2% during the 3rd quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock valued at $469,661,000 after purchasing an additional 127,769 shares in the last quarter. Finally, Assenagon Asset Management S.A. raised its holdings in shares of Axon Enterprise by 328.7% in the fourth quarter. Assenagon Asset Management S.A. now owns 145,299 shares of the biotechnology company’s stock worth $86,354,000 after buying an additional 111,405 shares during the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Axon Enterprise

In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the transaction, the director now owns 6,929 shares in the company, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Jeffrey C. Kunins sold 1,370 shares of the business’s stock in a transaction on Tuesday, December 17th. The stock was sold at an average price of $639.14, for a total transaction of $875,621.80. Following the completion of the sale, the insider now directly owns 125,950 shares of the company’s stock, valued at approximately $80,499,683. The trade was a 1.08 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 5,146 shares of company stock valued at $3,262,847 in the last ninety days. 6.10% of the stock is currently owned by corporate insiders.

Axon Enterprise Stock Performance

Shares of NASDAQ AXON opened at $528.28 on Wednesday. The company has a market capitalization of $40.28 billion, a PE ratio of 136.51, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The company’s fifty day moving average price is $607.58 and its 200 day moving average price is $526.43. Axon Enterprise, Inc. has a 1 year low of $273.52 and a 1 year high of $715.99.

Analyst Ratings Changes

A number of brokerages have recently weighed in on AXON. Barclays set a $726.00 price objective on shares of Axon Enterprise and gave the company an “overweight” rating in a report on Thursday, February 27th. Robert W. Baird boosted their price target on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Needham & Company LLC restated a “buy” rating and issued a $600.00 price objective on shares of Axon Enterprise in a research note on Wednesday, February 26th. TD Cowen assumed coverage on Axon Enterprise in a research report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 target price on the stock. Finally, Craig Hallum downgraded shares of Axon Enterprise from a “buy” rating to a “hold” rating and set a $625.00 price target on the stock. in a report on Thursday, February 20th. Three investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $587.38.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.